Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds
This special report, brought to MedChemNet members by Future Medicinal Chemistry, discusses progress in the development of novel anticancer drugs based on ruthenium(II)- and iron(II)-cyclopentadienyl scaffolds.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.